Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders
Hong Xin(Harbin Medical University), Napoleone Ferrara(Unknown), Cuiling Zhong(University of California San Diego), Tamara Chan(University of California San Diego), Nilima Biswas(University of California San Diego), Pin Li(University of California San Diego), Eric Nudleman(University of California San Diego)
Cited by 26
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
|Endocrine Reviews|2004|3.7k
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
|Journal of Biological Chemistry|1998|2k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
|Journal of Clinical Investigation|1995|698